Current Issue : October-December
Volume : 2022
Issue Number : 4
Articles : 1 Articles
Fungal infections have been a serious disease over a few decades, which affects individual of all ages, slowly reduce quality of life of patients and sometimes can be life-threatening. This problem gets compounded with the inappropriate and irrational use of medications. Thus, irrational usage of medications is becoming a global concern. Hence, aim of this study was to assess the distribution of fungal diseases and prescription pattern of antifungal medications to describe current treatment practices. A Prospective observational study was carried out in the dermatology OPD at NMCH and RC, Raichur for three months from May-2022 to July-2022. Prescriptions from patients satisfying inclusion criteria were collected directly by taking images and 70 prescriptions were reviewed. The results revealed that male patients were more 39 patients (56%). Most patients belonged to age group 21-30 years (26%) and 31- 40 (22.8%). Tinea cruris was the most prevalent fungal infection (32.8%). The majority of antifungal drugs prescribed were topical (64.5%). Creams (41.3%) were among the most prescribed dosage form. Ketoconazole was the drug prescribed mostly (20%). Imidazole class of antifungals was mostly prescribed (55.5%). Average number of drugs per encounter was 2.07 and generic drugs prescribed were 29%. The drug prescribed from the WHO EDL (Essential Drug List) was 41.3%. The study concluded that, the average number of drugs prescribed per encounter was more than the ideal value and the use of generic drugs should increase and also enhance the rational use of drugs....
� Copyright©2013. Inventi Journals Pvt.Ltd. All Right Reserved.